View in EDS HTML Full Text PDF Full Text

An anoikis-related gene signature predicts prognosis and immunotherapy response, and identifies CCAR2 as a therapeutic target in triple-negative breast cancer.

Saved in:
Bibliographic Details
Title: An anoikis-related gene signature predicts prognosis and immunotherapy response, and identifies CCAR2 as a therapeutic target in triple-negative breast cancer.
Authors: Chen Y; College of Clinical Medicine, Dali University, Dali, Yunnan, China., Lu X; College of Clinical Medicine, Dali University, Dali, Yunnan, China., Zhang L; College of Basic Medicine, Dali University, Dali, Yunnan, China., Li Y; College of Clinical Medicine, Dali University, Dali, Yunnan, China., Chen H; College of Basic Medicine, Dali University, Dali, Yunnan, China., Luo L; College of Clinical Medicine, Dali University, Dali, Yunnan, China., Pan Y; College of Clinical Medicine, Dali University, Dali, Yunnan, China.; Department of Pathology, The First Affiliated Hospital of Dali University, Dali, Yunnan, China., Gao B; College of Clinical Medicine, Dali University, Dali, Yunnan, China.; Department of Pathology, The First Affiliated Hospital of Dali University, Dali, Yunnan, China.
Source: Frontiers in immunology [Front Immunol] 2026 May 20; Vol. 17, pp. 1808490. Date of Electronic Publication: 2026 May 20 (Print Publication: 2026).
Publication Type: Journal Article
Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 42245636
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: An anoikis-related gene signature predicts prognosis and immunotherapy response, and identifies CCAR2 as a therapeutic target in triple-negative breast cancer.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Chen+Y%22">Chen Y</searchLink>; College of Clinical Medicine, Dali University, Dali, Yunnan, China.<br /><searchLink fieldCode="AU" term="%22Lu+X%22">Lu X</searchLink>; College of Clinical Medicine, Dali University, Dali, Yunnan, China.<br /><searchLink fieldCode="AU" term="%22Zhang+L%22">Zhang L</searchLink>; College of Basic Medicine, Dali University, Dali, Yunnan, China.<br /><searchLink fieldCode="AU" term="%22Li+Y%22">Li Y</searchLink>; College of Clinical Medicine, Dali University, Dali, Yunnan, China.<br /><searchLink fieldCode="AU" term="%22Chen+H%22">Chen H</searchLink>; College of Basic Medicine, Dali University, Dali, Yunnan, China.<br /><searchLink fieldCode="AU" term="%22Luo+L%22">Luo L</searchLink>; College of Clinical Medicine, Dali University, Dali, Yunnan, China.<br /><searchLink fieldCode="AU" term="%22Pan+Y%22">Pan Y</searchLink>; College of Clinical Medicine, Dali University, Dali, Yunnan, China.; Department of Pathology, The First Affiliated Hospital of Dali University, Dali, Yunnan, China.<br /><searchLink fieldCode="AU" term="%22Gao+B%22">Gao B</searchLink>; College of Clinical Medicine, Dali University, Dali, Yunnan, China.; Department of Pathology, The First Affiliated Hospital of Dali University, Dali, Yunnan, China.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101560960%22">Frontiers in immunology</searchLink> [Front Immunol] 2026 May 20; Vol. 17, pp. 1808490. <i>Date of Electronic Publication: </i>2026 May 20 (<i>Print Publication: </i>2026).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Frontiers+Research+Foundation]%22">Frontiers Research Foundation] </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>101560960 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Internet <i>ISSN: </i>1664-3224 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2216643224%22">16643224 </searchLink><i>NLM ISO Abbreviation: </i>Front Immunol <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=42245636
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.3389/fimmu.2026.1808490
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 1808490
    Titles:
      – TitleFull: An anoikis-related gene signature predicts prognosis and immunotherapy response, and identifies CCAR2 as a therapeutic target in triple-negative breast cancer.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Chen Y
      – PersonEntity:
          Name:
            NameFull: Lu X
      – PersonEntity:
          Name:
            NameFull: Zhang L
      – PersonEntity:
          Name:
            NameFull: Li Y
      – PersonEntity:
          Name:
            NameFull: Chen H
      – PersonEntity:
          Name:
            NameFull: Luo L
      – PersonEntity:
          Name:
            NameFull: Pan Y
      – PersonEntity:
          Name:
            NameFull: Gao B
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 20
              M: 05
              Text: 2026 May 20
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-electronic
              Value: 1664-3224
          Numbering:
            – Type: volume
              Value: 17
          Titles:
            – TitleFull: Frontiers in immunology
              Type: main
ResultId 1